Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient

Pancreatic cancer occurs more frequently in older patients, but these are underrepresented in the phase III clinical studies that established the current treatment standards. This leads to uncertainty regarding the treatment of older patients with potentially toxic but active regimens like FOLFIRINO...

Full description

Saved in:
Bibliographic Details
Main Authors: Berger, Anne Katrin (Author) , Haag, Georg Martin (Author) , Ehmann, Martin (Author) , Jäger, Dirk (Author) , Springfeld, Christoph (Author)
Format: Article (Journal)
Language:English
Published: 6 December 2017
In: BMC gastroenterology
Year: 2017, Volume: 17
ISSN:1471-230X
DOI:10.1186/s12876-017-0709-3
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12876-017-0709-3
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12876-017-0709-3
Get full text
Author Notes:Anne Katrin Berger, Georg Martin Haag, Martin Ehmann, Anne Byl, Dirk Jäger, Christoph Springfeld
Description
Summary:Pancreatic cancer occurs more frequently in older patients, but these are underrepresented in the phase III clinical studies that established the current treatment standards. This leads to uncertainty regarding the treatment of older patients with potentially toxic but active regimens like FOLFIRINOX.
Item Description:Gesehen am 25.04.2018
Physical Description:Online Resource
ISSN:1471-230X
DOI:10.1186/s12876-017-0709-3